Treatment for Magnesium Sulfate (MgSO4) Poisoning
The treatment for magnesium sulfate poisoning includes immediate administration of intravenous calcium (calcium chloride 10% 5-10 mL or calcium gluconate 10% 15-30 mL IV over 2-5 minutes), supportive care, and hemodialysis in severe cases. 1
Clinical Presentation of Magnesium Toxicity
- Hypermagnesemia is defined as a serum magnesium concentration >2.2 mEq/L (normal: 1.3 to 2.2 mEq/L) 1
- Neurological symptoms include muscular weakness, paralysis, ataxia, drowsiness, and confusion 1
- Cardiovascular manifestations include vasodilation, hypotension, bradycardia, and cardiac arrhythmias 1
- Respiratory depression and hypoventilation may occur at extremely high serum magnesium levels 1
- Progression to cardiorespiratory arrest is possible in severe cases 1, 2
First-Line Treatment
- Calcium administration: Intravenous calcium acts as a physiological antagonist to magnesium 1
- Calcium chloride (10%) 5-10 mL IV over 2-5 minutes, OR
- Calcium gluconate (10%) 15-30 mL IV over 2-5 minutes 1
- Discontinue any ongoing magnesium administration immediately 2
- Initiate cardiac monitoring and support vital functions 1
- Fluid therapy with normal saline to enhance renal excretion of magnesium 2
Supportive Measures
- Airway management and ventilatory support if respiratory depression is present 2
- Continuous cardiac monitoring for arrhythmias 1
- Correction of any other electrolyte abnormalities, particularly potassium 1
- Blood pressure support with vasopressors if hypotension persists despite calcium administration and fluid resuscitation 1
Advanced Treatment for Severe Cases
- Hemodialysis should be initiated promptly if:
Monitoring During Treatment
- Serial serum magnesium levels to guide therapy 2
- Continuous ECG monitoring for cardiac arrhythmias 1
- Frequent vital sign assessment, particularly respiratory rate and blood pressure 1
- Neurological status evaluation to track improvement in symptoms 1
- Renal function tests to assess kidney function and magnesium clearance 2
Special Considerations
- In pregnant patients with preeclampsia who received therapeutic magnesium sulfate, the same principles of treatment apply, but with careful attention to maternal and fetal monitoring 1
- In patients with renal impairment, hemodialysis should be considered earlier in the treatment course due to decreased ability to excrete magnesium 2
- For iatrogenic overdose (as in medication errors), identification of the exact dose administered helps guide the aggressiveness of treatment 2
Common Pitfalls to Avoid
- Delaying calcium administration while waiting for laboratory confirmation of hypermagnesemia when clinical signs strongly suggest magnesium toxicity 1
- Failing to consider hemodialysis early in severe cases or when conventional therapy is ineffective 2
- Overlooking the need for continuous cardiac monitoring during treatment 1
- Not recognizing that patients with renal dysfunction are at higher risk for prolonged magnesium toxicity and may require more aggressive intervention 2